Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1
- PMID: 20531209
- PMCID: PMC2943965
- DOI: 10.1097/QAI.0b013e3181e222c9
Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1
Abstract
Background: : We compared biomarkers of vascular dysfunction among HIV-infected children to a demographically similar group of uninfected children and determined factors associated with these biomarkers.
Methods and results: : We measured several biomarkers of vascular dysfunction: C-reactive protein (CRP), interleukin-6 (IL-6), and monocyte chemoattractant protein -1 (MCP-1) (inflammation); fibrinogen and P-selectin (coagulant dysfunction); soluble intracellular cell adhesion molecule-1 (sICAM), soluble vascular cell adhesion molecule-1 (sVCAM), and E-selectin (endothelial dysfunction); and leptin (metabolic dysfunction). Anthropometry, body composition, CD4%, HIV viral load, and antiretroviral therapy were recorded. Mean age was 14.8 years (106 HIV-infected children) and 12.3 years (55 control children). Sex and body mass index Z scores were similar. Infected children had higher sICAM, sVCAM, MCP-1, IL-6, and fibrinogen levels. E-selectin (P = 0.07), and CRP (P = 0.08) trended to be greater in the HIV group, yet leptin and P-selectin were similar. In multivariable analyses in the HIV-infected children alone, each 1 standard deviation increase in waist to hip ratio was associated with increases in sICAM (17%), MCP-1 (19%), IL6 (18%), and CRP (59%). CD4% was inversely associated with sVCAM, MCP-1, IL6, fibrinogen, and CRP.
Conclusions: : HIV-infected children have higher levels of biomarkers of vascular dysfunction than healthy children. Risk factors associated with these biomarkers include higher waist to hip ratios and HIV disease severity.
Conflict of interest statement
The authors have no potential, perceived, or real conflicts of interest.
Comment in
-
Vascular dysfunction biomarkers are elevated in children with HIV.Biomark Med. 2010 Oct;4(5):751. doi: 10.2217/bmm.10.85. Biomark Med. 2010. PMID: 20945989 No abstract available.
References
-
- Carr A, Samaras K, Chisholm DJ, Cooper DA. Abnormal fat distribution and use of protease inhibitors. Lancet. 1998 Jun 6;351(9117):1736. - PubMed
-
- Friis-Moller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003 Nov 20;349(21):1993–2003. - PubMed
-
- Libby P. Inflammation in atherosclerosis. Nature. 2002 Dec 19–26;420(6917):868–874. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
